Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts A Guide to Investing in Physical Gold October 9, 2025 Altech – Spherical Coated Silicon Achieves 88.5% Retention October 9, 2025 Nine Mile Metals Closes Oversubscribed Non Flow Through Private Placement October 9, 2025